Leviner, Dror B. https://orcid.org/0000-0003-2218-6072
von Mücke Similon, Miriam
Rosati, Carlo Maria
Amabile, Andrea
Thuijs, Daniel J. F. M.
Giammarco, Gabriele Di
Wendt, Daniel
Trachiotis, Gregory D.
Kieser, Teresa M.
Kappetein, A. Pieter
Head, Stuart J.
Taggart, David P.
Puskas, John D.
Article History
Received: 16 April 2021
Accepted: 29 June 2021
First Online: 9 July 2021
Declarations
:
: Institutional Review Board approval from each participating center prior to screening and enrollment, and informed consent from all enrolled patients was obtained (IRB approval number for the various institutions: Site 1–30 June 2015 ref. 15–63060-BO, Site 2–23 April 2015 ref. REB15–0090, Site 3–6 Aug 2015 ref. HS#.053–15, Site 4–18 June 2015, Site 5–22 April 2015 ref. 15/SC/0194, Site 6–24 April 2015 ref. 01731, Site 7–20 July 2015 ref. MEC-2015-448).
: Not applicable.
: DBL – None, MvMS – None, CR – None, AA – None, DJT - Medistim. Travelling support/speaking fees, GDG - Medistim. Travelling support/speaking fees, DW - Medistim. Travelling support/speaking fees, GDT – None, TMK - Medistim. Travelling support/speaking fees, APK - Medistim. Travelling support/speaking fees. Medtronic Employment, SJH - Medistim. Travelling support/speaking fees. Medtronic Employment, DPT - Medistim. Research funding, speaking and travelling honoraria, consultant, JDP - Medistim. Travelling support/speaking fees.